Selective CDK9 degradation using a proteolysis-targeting chimera (PROTAC) strategy

Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean, Amarnath Natarajan

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)131-134
Number of pages4
JournalFuture Medicinal Chemistry
Volume14
Issue number3
DOIs
StatePublished - Jan 2022
Externally publishedYes

Keywords

  • CDK9
  • PROTAC
  • cancer
  • degrader

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this